Jinxin Fertility Group Limited (HKG:1951)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.860
-0.050 (-1.72%)
Jun 5, 2025, 3:45 PM HKT
-10.34%
Market Cap 7.91B
Revenue (ttm) 2.99B
Net Income (ttm) 301.27M
Shares Out 2.76B
EPS (ttm) 0.11
PE Ratio 26.97
Forward PE 15.74
Dividend 0.06 (2.08%)
Ex-Dividend Date Jun 27, 2024
Volume 41,496,831
Average Volume 42,109,233
Open 2.910
Previous Close 2.910
Day's Range 2.850 - 2.960
52-Week Range 2.070 - 4.640
Beta 1.40
RSI 53.61
Earnings Date May 29, 2025

About Jinxin Fertility Group

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. It primarily offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. The company also provides related services, such as nutrition guidance, Chinese medicine treatment, an... [Read more]

Sector Healthcare
Founded 1951
Employees 3,198
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1951
Full Company Profile

Financial Performance

In 2024, Jinxin Fertility Group's revenue was 2.81 billion, an increase of 0.81% compared to the previous year's 2.79 billion. Earnings were 283.10 million, a decrease of -17.88%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.